Pyrogenesis Canada Inc
Change company Symbol lookup
Select an option...
PYR Pyrogenesis Canada Inc
CHRA Charah Solutions Inc
FTIIU Futuretech II Acquisition Corp
JBL Jabil Inc
AZO Autozone Inc
ALHC Alignment Healthcare Inc
PRGS Progress Software Corp
PMD Psychemedics Corp
RPHM Reneo Pharmaceuticals Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Industrials : Commercial Services & Supplies | Small Cap Blend
Based in Canada
Company profile

PyroGenesis Canada Inc. is a Canada-based technology company. The Company is engaged in the design, development, manufacture and commercialization of advanced plasma processes and sustainable solutions, which reduce greenhouse gases. Its products and services include Plasma Atomized Metal Powders, Aluminum and Zinc Dross Recovery: DROSRITE, waste management, plasma torches, and Innovation / Custom Process Development, among others. It offers products across various industries. The Company provides engineering and manufacturing expertise, contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing, including three-dimensional (3D) printing, oil and gas, and environmental industries. It provides plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. It offers technologies, equipment, and expertise in biogas upgrading, and air pollution control.

Closing Price
Day's Change
-0.07 (-7.95%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

GE HealthCare reports first results after GE spinoff, with revenue rising 8% but profit slipping

6:40 am ET January 30, 2023 (MarketWatch)

Shares of GE HealthCare (GEHC) slipped 0.1% in premarket trading Monday, after the medical technology and pharmaceutical diagnostics company reported its first results as a public company, with fourth-quarter profit falling from a year ago while revenue rose. The company, which completed its spinoff from General Electric Co. (GE) on Jan. 3, said net income slipped 1.8% to $554 million, as earning per share from continuing operations fell to $1.21 from $1.24. Excluding nonrecurring items, adjusted EPS fell to $1.31 from $1.36, while standalone adjusted EPS, which includes standalone costs, was $1.21. Revenue grew 7.6% to $4.94 billion. Cost of products and services sold rose more than revenue, up 10.2% to $3.01 billion, as gross margin contracted to 39.1% from 40.6%. There were no consensus estimated for quarterly results from FactSet. The company expects 2023 adjusted EPS of $3.60 to $3.75, up from 2022 standalone adjusted EPS of $3.38. "We're seeing customers continue to invest along with macroeconomic tailwinds, such as increasing healthcare digitization, expanding access to care, and an aging population globally," said GE HealthCare Chief Executive Peter Arduni. While the stock edged lower after results, it outperformed the broader stock market, as futures for the S&P 500 dropped 1.0%.

-Tomi Kilgore


(END) Dow Jones Newswires

January 30, 2023 06:40 ET (11:40 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.